Connection

Guillermo Umpierrez to Dipeptidyl-Peptidase IV Inhibitors

Back to Details
This is a "connection" page, showing publications Guillermo Umpierrez has written about Dipeptidyl-Peptidase IV Inhibitors.
Guillermo Umpierrez
Connection Strength
0.848
Dipeptidyl-Peptidase IV Inhibitors
  1. A Randomized Controlled Study Comparing a DPP4 Inhibitor (Linagliptin) and Basal Insulin (Glargine) in Patients With Type 2 Diabetes in Long-term Care and Skilled Nursing Facilities: Linagliptin-LTC Trial. J Am Med Dir Assoc. 2018 05; 19(5):399-404.e3.
    View in: PubMed
    Score: 0.480
  2. Glycaemic efficacy and safety of linagliptin compared to a basal-bolus insulin regimen in patients with type 2 diabetes undergoing non-cardiac surgery: A multicentre randomized clinical trial. Diabetes Obes Metab. 2019 04; 21(4):837-843.
    View in: PubMed
    Score: 0.128
  3. Sitagliptin for prevention of stress hyperglycemia in patients without diabetes undergoing general surgery: A pilot randomized study. J Diabetes Complications. 2018 Dec; 32(12):1091-1096.
    View in: PubMed
    Score: 0.126
  4. Management of Inpatient Hyperglycemia and Diabetes in Older Adults. Diabetes Care. 2017 Apr; 40(4):509-517.
    View in: PubMed
    Score: 0.114
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.